Suven Pharmaceuticals: Global private equity firm Advent International has merged two of its pharmaceutical portfolio firms, Cohance Lifesciences and Suven Pharmaceuticals, according to a joint announcement. The merged entity will have three distinct business units – Pharma CDMO, Spec Chem CDMO, and API+ (inclusive of formulations), the release said.